Human Immunology News 7.28 July 23, 2019 | |
| |
TOP STORYFingerprint of Multiple Sclerosis Immune Cells Identified Researchers identified a cell population that likely plays a key role in multiple sclerosis (MS). T helper cells in the blood of MS patients infiltrate the central nervous system, where they can cause inflammation and damage nerve cells. [Press release from the University of Zurich discussing online prepublication in Nature Medicine] Press Release | Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Scientists report a fatal case of encephalitis arising during anti-programmed cell death receptor 1 therapy in a patient with metastatic melanoma. Histologic analyses revealed robust T cell infiltration and prominent programmed death ligand 1 expression. [Nat Med] Abstract | Press Release Using single cell RNA-sequencing of human peripheral blood cells infected with Salmonella, the authors developed a deconvolution algorithm for inferring cell-type specific infection responses from bulk measurements. [Nat Commun] Full Article | Press Release Investigators applied single molecule-sensitive direct stochastic optical reconstruction microscopy, and demonstrated CD19 expression on a fraction of myeloma cells in 10 out of 14 patients. [Nat Commun] Full Article Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy To broadly enumerate immune cell identity and activity, scientists established and extensively assessed a reference panel of 33 antibodies to cover major cell subsets, simultaneously quantifying activation and immune checkpoint molecules in a single assay. [Cell Rep] Full Article | Graphical Abstract Researchers elucidated the role of hepatoma-derived growth factor (HDGF) in H. pylori-induced gastric inflammation and carcinogenesis. HDGF expression in gastric biopsy and serum from patients was analyzed by immunohistochemical and ELISA analysis, respectively. [Oncogene] Abstract Scientists found a significant upregulation of signaling lymphocytic activation molecule family member 3 (SLAMF3) expression on T cells from type 2 diabetes patients compared to those of healthy controls. [Cell Death Dis] Full Article The authors constructed target modules (TMs) against prostate stem cell antigen equipped with or lacking an oligo-His-tag. Both TMs were compared side by side for functionality and biodistribution. [Sci Rep] Full Article Silencing RORγt in Human CD4+ T Cells with CD30 Aptamer-RORγt shRNA Chimera Investigators report that an RNA CD30 aptamer was utilized to deliver short hairpin RNA (shRNA) to CD30+ T cells to target retinoic acid receptor-related orphan receptor gamma t (RORγt), leading to impaired expression of RORγt and suppression of IL-17A and IL-17F. [Sci Rep] Full Article Subscribe to our sister publications: Immunology of Infectious Disease News & Immune Regulation News. | |
| |
REVIEWSTherapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond Disease-specific CD4+ T cells form an immunological scar in celiac disease and probably other autoimmune disorders. The authors discuss how such T cells may be targeted for better treatment and diagnosis via their antigen specificity or via their expression of characteristic phenotypic markers. [Trends Mol Med] Full Article Visit our reviews page to see a complete list of reviews in the human immunology research field. | |
| |
INDUSTRY NEWSAvalon GloboCare Corp. announced that they have established a strategic partnership with GE Healthcare. The partnership will accelerate Avalon’s standardization, automation and bio-production for clinical-grade CAR-T cells and other immune-effector cells for cellular immunotherapy, as well as exosomes/extracellular vesicles based regenerative therapeutics. [Avalon GloboCare Corp.] Press Release Adaptimmune Therapeutics plc has initiated SURPASS, its first clinical trial with a next-generation SPEAR T-cell targeting MAGE-A4. [Adaptimmune Therapeutics plc] Press Release | |
| |
POLICY NEWSBudget Deal Raises Hopes for US Research Agencies A new budget deal between the White House and congressional leaders means US research agencies could receive increases on the order of the 4% to 5% that Democrats have already proposed for next year. [ScienceInsider] Editorial What Boris Johnson’s Leadership Could Mean for Science Boris Johnson has been selected as the United Kingdom’s new prime minister — and is poised to lead the country out of the European Union. At the forefront of many scientists’ minds are questions about how Johnson’s leadership, including his support for a ‘no deal’ Brexit, will affect research. They fear that British science has much to lose from a messy departure from the EU. [Nature News] Editorial
| |
EVENTSNEW 2019 National Cancer Research Institute (NCRI) Cancer Conference Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Scientific Communications Coordinator (STEMCELL Technologies Inc.) NEW Preclinical Scientist – Immunology (MiroBio) Research Associate – Human Immunology (STEMCELL Technologies Inc.) Scientist – Human Immunology (STEMCELL Technologies Inc.) Research Associate – Immune Cell Culture (STEMCELL Technologies Inc.) PhD Position – Extracellular Matrix & Skin Immunology (University of Freiburg) Postdoctoral Position – Mucosal Immunology (University of California San Diego) Postdoctoral Research Scientist – Molecular Immunology (Babraham Institute) PhD Fellowship – Immunology (University of Oslo) Postdoctoral Fellow – Tumor Immunology (Massachusetts General Hospital and Harvard Medical School) Senior Research Assistant – Immunology (MD Anderson Cancer Center) Postdoctoral Fellow – Immunology (Boston University) Postdoctoral Position – Immunology of Enteric Infections (University of Utah) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Human Immunology News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|